Application of modified Curie and SIOPEN skeleton scoring systems in 18F-AlF-NOTA-octreotide PET/CT for neuroblastoma
Annals of Nuclear Medicine · 2025
DOI: 10.1007/s12149-024-02006-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Nuclear Medicine, 2025. Verfasst von Siqi Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xicheng District, Beijing, 100050, China. Hauptthemen laut MEDLINE: Neuroblastoma, Positron Emission Tomography Computed Tomography, Octreotide. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, Xicheng District Science and Technology Special Project Plan.
Abstract (Originalsprache)
OBJECTIVE: The study aimed to explore the role of fluorine-18-aluminum fluoride-1,4,7-triazacyclononane-1,4,7-triacetic acid-octreotide (18F-OC) positron emission tomography/computed tomography (PET/CT) in neuroblastoma (NB) and compared it with Iodine-123 labeled metaiodobenzylguanidine (123I-MIBG) scintigraphy with single photon emission computed tomography/computed tomography (SPECT/CT), as well as to investigate the feasibility of the modified Curie scoring system and International Society of Pediatric Oncology Europe Neuroblastoma (SIOPEN) skeleton scoring system applied in 18F-OC PET/CT. METHODS: Patients with pathologically confirmed NB underwent 123I-MIBG scintigraphy with SPECT/CT and 18F-OC PET/CT according the standard imaging protocols. The interval between the two imaging techniques ranged from 0 to 22 days (median interval: 9 days). The number of lesions in modified Curie scoring system and SIOPEN skeleton scoring system applied on 123I-MIBG SPECT/CT and 18F-OC PET/CT was compared. RESULTS: A total of 50 NB patients (male: female = 25:25) with a median age of 62-month-old were enrolled. 123I-MIBG and 18F-OC imaging were positive in 22 patients and negative in 27 patients. 1 patient had positive 18F-OC but negative 123I-MIBG results (p = 1.000). In lesion-based analysis, 18F-OC PET/CT revealed more positive lesions than 123I-MIBG scintigraphy with SPECT/CT (57 vs. 44, p < 0.001), regardless of bone/bone marrow lesions (43 vs. 37, p = 0.031) or soft tissue lesions (14 vs. 7, p = 0.016). The Curie scores of the two imaging techniques showed a significant difference (p = 0.047), whereas no statistic difference for SIOPEN scores (p = 0.688). The Curie and SIOPEN scores were significantly higher in patients with the presence of MYCN amplification or positive bone marrow puncture result (p < 0.05). CONCLUSION: 18F-OC could be used in the evaluation of NB, and the modified Curie scoring system could be used to semi-quantify the disease extent of NB in 18F-OC PET/CT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xicheng District, Beijing, 100050, China.
- Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
- Nuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xicheng District, Beijing, 100050, China. yangjigang@ccmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Xicheng District Science and Technology Special Project Plan
- Capital's Funds for Health Improvement and Research
- Beijing Friendship Hospital Seed Project of Capital Medical University
- National Key Research and Development Plan
- Capital’s Funds for Health Improvement and Research
Zitieren
APA
Li, S., Sang, B., Liu, J., Liu, Y., Xu, Y., Sun, X., & Yang, J. (2025). Application of modified Curie and SIOPEN skeleton scoring systems in 18F-AlF-NOTA-octreotide PET/CT for neuroblastoma. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-024-02006-3
Vancouver
Li S, Sang B, Liu J, Liu Y, Xu Y, Sun X, et al. Application of modified Curie and SIOPEN skeleton scoring systems in 18F-AlF-NOTA-octreotide PET/CT for neuroblastoma. Annals of Nuclear Medicine. 2025. doi:10.1007/s12149-024-02006-3
BibTeX
@article{Li2025,
author = {Li, Siqi and Sang, Baojun and Liu, Jun and Liu, Yuxuan and Xu, Yanfeng and Sun, Xiaorong and Yang, Jigang},
title = {Application of modified Curie and SIOPEN skeleton scoring systems in 18F-AlF-NOTA-octreotide PET/CT for neuroblastoma},
journal = {Annals of Nuclear Medicine},
year = {2025},
doi = {10.1007/s12149-024-02006-3}
}
EUVIMED